EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Handshake on blue background

Boehringer and Tessellate partner to tackle tough cancer targets

Boehringer Ingelheim and Tessellate Bio form a €500m partnership to develop precision therapies.

US pharma tariffs: What they mean for drug prices

US drug tariffs may not hit branded prices hard, but generics and supply chains face disruption. Here’s what pharma leaders need to know.

Scientists crack the code for keeping lab-grown tissue alive

FluidForm Bio’s 3D bioprinting tech keeps lab-grown cells alive five times deeper using vascular-like gelatin scaffolds.
Illustration of signed papers

UK enacts new clinical trial regulations

The UK government has formally signed into law new clinical trial regulations, designed to modernise operations across the country.
Lightening bolt on grey background

New tool supercharges lipid nanoparticle analysis

CloudSpec speeds up lipid nanoparticle analysis, cutting lab times from hours to seconds for gene therapy and vaccine research.
British government buildings

UK government unveils Health Data Research Service

The UK government has announced a significant new initiative to accelerate drug discovery and improve patient care in the country.  

Pharma must balance creativity and trust in 2025, says VML

Pharma must balance creativity with transparency to rebuild trust in 2025. VML Health’s report reveals key trends shaping expectations.
Colourful arrows going in different directions on a grey background

Novo Nordisk announces significant leadership reshuffle

Novo Nordisk has announced major leadership changes, with EVP Camilla Sylvest departing and Ludovic Helfgott taking on an expanded role.
We’ve noticed you’re accessing
from North/South America.